Evidence map›Paper›PMID 28744708›Full record

ReviewAnnals of nuclear medicine2017

Topics of nuclear medicine research in Europe.

Masayuki Inubushi, Tomohiro Kaneta, Takayoshi Ishimori, Etsuko Imabayashi, Atsutaka Okizaki, Naohiko Oku

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of nuclear medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Masayuki InubushiDivision of Nuclear Medicine, Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. inubushi@med.kawasaki-m.ac.jp.ORCID http://orcid.org/0000-0002-2518-7890
Tomohiro KanetaDepartment of Radiology, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Takayoshi IshimoriDepartment of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyoku, Kyoto, 606-8507, Japan.
Etsuko ImabayashiIntegrative Brain Imaging Center, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, 187-8551, Japan.
Atsutaka OkizakiDepartment of Radiology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-higashi, Asahikawa, 078-8510, Japan.
Naohiko OkuHIMEDIC Clinic WEST, 3-3-17 Minami Senba, Chuo-ku, Osaka, 542-0081, Japan.
Asahikawa Medical University · JPKawasaki Medical School · JPKyoto University · JPNational Center of Neurology and Psychiatry · JPYokohama City University · JP

Funding

Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Publication of Scientific Research Results (Strengthening international dissemination of information (A); No.251002)
6 · The paper itself

Abstract

Last year in the European Journal of Nuclear Medicine and Molecular Imaging, we introduced some recent nuclear medicine research conducted in Japan. This was favorably received by European readers in the main. This year we wish to focus on the Annals of Nuclear Medicine on some of the fine nuclear medicine research work executed in Europe recently. In the current review article, we take up five topics: prostate-specific membrane antigen imaging, recent advances in radionuclide therapy, [

Indexed as

Biomedical ResearchDementiaEuropeFemaleHumansMaleMyocardial Perfusion ImagingNuclear MedicinePositron-Emission TomographyProstatic NeoplasmsRadiotherapyDementiaIodine-124 (124I)Prostate-specific membrane antigen (PSMA)Quantitative myocardial perfusion PETRadionuclide therapy

Identifiers

PMID28744708
PMCPMC5622907
OpenAlexW2737463911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.